Leffler Abba E, Houang Evelyne M, Gray Felicia, Placzek Andrew T, Ruvinsky Anatoly M, Bell Jeffrey A, Wang Hui, Sun Shaoxian, Svensson Mats, Greenwood Jeremy R, Frye Leah L, Igawa Hideyuki, Atsriku Christian, Levinson Adam M
Schrödinger, Inc., New York, New York 10036, United States.
Schrödinger, Inc., Portland, Oregon 97204, United States.
ACS Med Chem Lett. 2025 Feb 28;16(3):444-453. doi: 10.1021/acsmedchemlett.4c00602. eCollection 2025 Mar 13.
Small molecules that bind the Son of Sevenless 1 protein (SOS1), thereby preventing activation of RAS, have been widely pursued as a means for cell proliferation inhibition and antitumor activity. Guided by free-energy perturbation (FEP+) simulations, we discovered that two acidic residues on the perimeter of a known small molecule binding site on SOS1, E906 and E909, constitute a potency handle that can improve inhibitor affinity by as much as 750-fold when targeted with basic groups to form salt bridges, despite being solvent exposed. Structure-Activity Relationship (SAR) and X-ray crystallographic studies demonstrate that this effect is attributable to the electrostatic interaction between the protein and ligand. This interaction could be repurposed to create new SOS1 inhibitors, documenting its general utility for core exploration. Additional recent examples in the literature suggest that this phenomenon may be applicable to a number of target classes and are highlighted herein.
与七号less之子1蛋白(SOS1)结合从而阻止RAS激活的小分子,已被广泛研究作为抑制细胞增殖和抗肿瘤活性的一种手段。在自由能微扰(FEP+)模拟的指导下,我们发现SOS1上一个已知小分子结合位点周边的两个酸性残基E906和E909,构成了一个效能调控位点,当用碱性基团靶向形成盐桥时,尽管它们暴露于溶剂中,但可将抑制剂亲和力提高多达750倍。构效关系(SAR)和X射线晶体学研究表明,这种效应归因于蛋白质与配体之间的静电相互作用。这种相互作用可被重新利用来创建新的SOS1抑制剂,证明了其在核心探索中的普遍效用。文献中最近的其他例子表明,这种现象可能适用于许多靶点类别,并在此予以强调。